High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.

Cite this paper

@article{Montalescot2014HighOP, title={High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study.}, author={Gilles Montalescot and Gr{\'e}goire Rang{\'e} and Johanne Silvain and Jean-louis Bonnet and Ziad Boueri and Olivier Barth{\'e}l{\'e}my and Guillaume Cayla and Lo{\"{i}c Belle and {\'E}ric Van Belle and Thomas Cuisset and Simon Elhadad and Christophe Pouillot and Patrick Henry and Pascal Motreff and Didier Carri{\'e} and H. Rousseau and Pierre Aubry and Jacques Mons{\'e}gu and Pierre Sabouret and Stephen A. O'Connor and J{\'e}r{\'e}mie Abtan and Mathieu Kerneis and Christophe Saint-Etienne and Farzin Beygui and {\'E}ric Vicaut and J. P. Collet}, journal={Circulation}, year={2014}, volume={129 21}, pages={2136-43} }